Comparative Effectiveness of Alginate, Magaldrate, Sucralfate, Proton Pump Inhibitors, and Diet in Laryngopharyngeal Reflux Disease

Comparative Effectiveness of Alginate, Magaldrate, Sucralfate, Proton Pump Inhibitors, and Diet in Laryngopharyngeal Reflux Disease

The goal of this randomized controlled trial is to compare the effectiveness of different treatments for laryngopharyngeal reflux disease (LPRD) in adult patients with confirmed symptoms and signs of the condition. The main question it aims to answer is:

Which treatment (Proton Pump Inhibitors (PPIs), alginate, magaldrate, sucralfate, or diet) leads to the greatest improvement in LPRD symptoms and clinical signs over 3 months? Researchers will compare proton pump inhibitors to alternative medical treatments and dietary management to see which approach is most effective and better tolerated.

Participants will:

• undergo a clinical ENT examination with scoring of reflux signs (RSA)
• complete symptom questionnaires (RSS) assessing severity, frequency, and impact of symptoms
• receive one of the study treatments (medication or dietary intervention)
• be evaluated at baseline and again after 3 months of treatment

Inclusion Criteria:

• Positive 24-h HEMII-pH > 1 event

Exclusion Criteria:

• Smoker (>5 cigarettes/day) , alcohol dependence (>3 units/day),
• upper respiratory tract infection within the last month,
• pregnancy,
• neurological or psychiatric illness,
• previous history of neck surgery or trauma,
• malignancy,
• history of head and neck radiotherapy
• active seasonal allergies or asthma.